Literature DB >> 12496326

Cardiac involvement in HIV infected people in Yaounde, Cameroon.

D Nzuobontane1, K N Blackett, C Kuaban.   

Abstract

OBJECTIVE: To study the cardiac abnormalities in HIV infected patients in relation to the clinical stage of the disease and the immunological status of the patients.
METHODS: A total 75 consecutive patients tested for HIV on the basis of clinical suspicion of the disease from July to September 1996 at the University Hospital Centre, Yaounde, Cameroon were recruited. The patients were classified into AIDS, HIV positive non-AIDS, and HIV negative according to clinical findings and outcome of ELISA and western blot testing. Every patient underwent a clinical examination, two dimensional and M-mode echocardiography, and blood lymphocyte typing.
RESULTS: Dilated cardiomyopathy occurred in 7/30 (23.33%) AIDS patients, 1/24 (4.17%) HIV positive non-AIDS patient, but in none of the HIV negative patients. Other echocardiographic abnormalities included pericardial separation, effusion, thickening, and mitral valve prolapse. Although these abnormalities were more frequent in HIV infected patients, the differences did not reach levels of statistical significance. Dilated cardiomyopathy occurred in six (31.58%) of the patients with a CD4 cell count < or =100/mm(3) and two (6.06%) in those with absolute CD4 counts >100/mm(3) (chi(2) = 4.02, p = 0.03).
CONCLUSIONS: Cardiovascular abnormalities are frequent in African HIV infected patients but clinically discrete. Low CD4 cell counts are associated with dilated cardiomyopathy. These abnormalities should be expected with greater frequency in cardiological clinical practice as management of opportunistic infections improves in a situation of continued high disease prevalence in Africa.

Entities:  

Mesh:

Year:  2002        PMID: 12496326      PMCID: PMC1742549          DOI: 10.1136/pmj.78.925.678

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  23 in total

1.  Myocardial infarction in HIV-infected men receiving protease inhibitors.

Authors:  T E Flynn; L A Bricker
Journal:  Ann Intern Med       Date:  1999-10-05       Impact factor: 25.391

Review 2.  Cardiovascular manifestations of HIV infection.

Authors:  G Barbaro
Journal:  J R Soc Med       Date:  2001-08       Impact factor: 5.344

3.  Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection: a report of six cases.

Authors:  A Herskowitz; S B Willoughby; K L Baughman; S P Schulman; J D Bartlett
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

4.  Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.

Authors:  S E Lipshultz; K A Easley; E J Orav; S Kaplan; T J Starc; J T Bricker; W W Lai; D S Moodie; G Sopko; S D Colan
Journal:  Circulation       Date:  2000-09-26       Impact factor: 29.690

5.  Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection.

Authors:  A Herskowitz; D Vlahov; S Willoughby; R E Chaisson; S P Schulman; D A Neumann; K L Baughman
Journal:  Am J Cardiol       Date:  1993-04-15       Impact factor: 2.778

Review 6.  HIV-associated pericardial effusions.

Authors:  M J Eisenberg; A S Gordon; N B Schiller
Journal:  Chest       Date:  1992-09       Impact factor: 9.410

7.  Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study.

Authors:  R B Himelman; W S Chung; D N Chernoff; N B Schiller; H Hollander
Journal:  J Am Coll Cardiol       Date:  1989-04       Impact factor: 24.094

8.  Heart muscle disease related to HIV infection: prognostic implications.

Authors:  P F Currie; A J Jacob; A R Foreman; R A Elton; R P Brettle; N A Boon
Journal:  BMJ       Date:  1994-12-17

9.  Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus.

Authors:  M J Domanski; M M Sloas; D A Follmann; P P Scalise; E E Tucker; D Egan; P A Pizzo
Journal:  J Pediatr       Date:  1995-07       Impact factor: 4.406

10.  Pericardial disease and human immunodeficiency virus in Dar es Salaam, Tanzania.

Authors:  J P Cegielski; K Ramiya; G J Lallinger; I A Mtulia; I M Mbaga
Journal:  Lancet       Date:  1990-01-27       Impact factor: 79.321

View more
  17 in total

Review 1.  HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research.

Authors:  Gerald S Bloomfield; Prateeti Khazanie; Alison Morris; Cristina Rabadán-Diehl; Laura A Benjamin; David Murdoch; Virginia S Radcliff; Eric J Velazquez; Charles Hicks
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

2.  Heart and HAART: Two sides of the coin for HIV-associated cardiology issues.

Authors:  Giuseppe Barbaro
Journal:  World J Cardiol       Date:  2010-03-26

Review 3.  Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries.

Authors:  Gerald S Bloomfield; Fawaz Alenezi; Felix A Barasa; Rebecca Lumsden; Bongani M Mayosi; Eric J Velazquez
Journal:  JACC Heart Fail       Date:  2015-08       Impact factor: 12.035

Review 4.  Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa.

Authors:  Bongani M Mayosi
Journal:  Heart       Date:  2007-10       Impact factor: 5.994

Review 5.  Cardiac manifestations of HIV infection: an African perspective.

Authors:  Mpiko Ntsekhe; Bongani M Mayosi
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-12-23

6.  Patterns of cardiovascular disease in a group of HIV-infected adults in Yaoundé, Cameroon.

Authors:  Alain Patrick Menanga; Christelle Kougang Ngomseu; Ahmadou M Jingi; Brigitte Molu Mfangam; Jean Jacques N Noubiap; Marie Ntep Gweth; Kathleen Ngu Blackett; Samuel Kingue
Journal:  Cardiovasc Diagn Ther       Date:  2015-12

7.  Echocardiographic abnormalities in children and adolescents living with human immunodeficiency virus on highly active antiretroviral treatment.

Authors:  Tewolde Wubayehu; Workeabeba Abebe; Endale Tefera
Journal:  Cardiovasc J Afr       Date:  2020-02-05       Impact factor: 1.167

8.  Echocardiographic and electrocardiographic abnormalities in adults living with human immunodeficiency virus: a cross-sectional study in the Yaoundé Central Hospital, Cameroon.

Authors:  Ba Hamadou; Marie Ntep Ngweth; Miriam Megueo Fotso; Liliane Mfeukeu-Kuate; Ahmadou M Jingi; Jean Jacques Noubiap; Chris Nadege Nganou; Jerome Boombhi; Sylvie Ndongo Amougou; Alain Menanga; Samuel Kingue
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

9.  Echocardiographic diagnoses in HIV-infected patients presenting with cardiac symptoms at Muhimbili National Hospital in Dar es Salaam, Tanzania.

Authors:  Pilly Chillo; Myhammad Bakari; Johnson Lwakatare
Journal:  Cardiovasc J Afr       Date:  2012-02-13       Impact factor: 1.167

Review 10.  Heart failure in sub-Saharan Africa.

Authors:  Gerald S Bloomfield; Felix A Barasa; Jacob A Doll; Eric J Velazquez
Journal:  Curr Cardiol Rev       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.